BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12161382)

  • 1. Two new molecular PML-RARalpha variants: implications for the molecular diagnosis of APL.
    Vizmanos JL; Larrráyoz MJ; Odero MD; Lasa R; González M; Novo FJ; Calasanz MJ
    Haematologica; 2002 Aug; 87(8):ELT37. PubMed ID: 12161382
    [No Abstract]   [Full Text] [Related]  

  • 2. Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response.
    Cassinat B; Guillemot I; Moluçon-Chabrot C; Zassadowski F; Fenaux P; Tournilhac O; Chomienne C
    Haematologica; 2006 Dec; 91(12 Suppl):ECR58. PubMed ID: 17194664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of atypical PML-RARA breakpoint in a patient with acute promyelocytic leukemia.
    Ismail S; Ababneh N; Awidi A
    Acta Haematol; 2007; 118(3):183-7. PubMed ID: 17934255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmation.
    Eclache V; Viguie F; Frocrain C; Cassinat B; Chomienne C; Cymbalista F; Fenaux P
    Cancer Genet Cytogenet; 2005 May; 159(1):69-73. PubMed ID: 15860361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel, non-nested reverse-transcriptase polymerase chain reaction (RT-PCR) test for the detection of the t(15;17) translocation: a comparative study of RT-PCR cytogenetics, and fluorescence In situ hybridization.
    Rennert H; Golde T; Wilson RB; Spitalnik SL; Van Deerlin VM; Leonard DG
    Mol Diagn; 1999 Sep; 4(3):195-209. PubMed ID: 10553020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia.
    Lo Coco F; Diverio D; Avvisati G; Mandelli F
    Haematologica; 1999 Jun; 84 Suppl EHA-4():72-4. PubMed ID: 10907474
    [No Abstract]   [Full Text] [Related]  

  • 7. Variant acute promyelocytic leukemia translocation (15;17) originating from two subsequent balanced translocations involving the same chromosomes 15 and 17 while preserving the PML/RARA fusion.
    Tirado CA; Jahn JA; Scheerle J; Eid M; Meister RJ; Christie RJ; Croft CD; Wallingford S; Heritage DW; Mowrey PN; Meloni-Ehrig AM
    Cancer Genet Cytogenet; 2005 Aug; 161(1):70-3. PubMed ID: 16080960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptic insertion (15;17) in a case of acute promyelocytic leukemia detected by fluorescence in situ hybridization.
    Gutiérrez NC; García JL; Chillón C; Muntión S; González M; Hernández JM
    Haematologica; 1999 Jan; 84(1):88-90. PubMed ID: 10091399
    [No Abstract]   [Full Text] [Related]  

  • 9. A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia.
    García-Casado Z; Cervera J; Valencia A; Pajuelo JC; Mena-Duran AV; Barragán E; Bolufer P; Sanz MA
    Cancer Genet Cytogenet; 2006 Jul; 168(1):73-6. PubMed ID: 16772124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characterization of the universal Russian reagent sets for real-time PCR and its application for molecular oncodiagnostic].
    Manzeniuk OIu; Malakho SG; Pekhov VM; Kosorukova IS; Poltaraus AB
    Mol Biol (Mosk); 2006; 40(2):349-56. PubMed ID: 16637276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two new 3' PML breakpoints in t(15;17)(q22;q21)-positive acute promyelocytic leukemia.
    Chillón MC; González M; García-Sanz R; Balanzategui A; González D; López-Pérez R; Mateos MV; Alaejos I; Rayón C; Arbeteta J; Hernández JM; Orfao A; San Miguel J
    Genes Chromosomes Cancer; 2000 Jan; 27(1):35-43. PubMed ID: 10564584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytogenetic and molecular genetic studies on a variant of t(15;17), ins(17;15)(q21;q14q22), in an acute promyelocytic leukemia patient].
    Chen SN; Xue YQ; Wu YF; Pan JL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):77-9. PubMed ID: 14767917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute promyelocytic leukemia with del(6)(p23).
    Nakase K; Wakita Y; Minamikawa K; Yamaguchi T; Shiku H
    Leuk Res; 2000 Jan; 24(1):79-81. PubMed ID: 10634650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level.
    Martinelli G; Ottaviani E; Visani G; Testoni N; Montefusco V; Tura S
    Haematologica; 1998 Sep; 83(9):860-3. PubMed ID: 9825588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of t(15;17) using cytogenetic, fluorescent in situ hybridization, and molecular techniques. Comparative study of 11 patients with acute promyelocytic leukemia].
    Arranz E; Robledo M; Martínez B; Prieto E; Román A; Benítez J
    Sangre (Barc); 1997 Feb; 42(1):11-5. PubMed ID: 9229797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The APL-associated fusion proteins.
    Minucci S; Cioce M; Maccarana M; Pelicci PG
    Haematologica; 1999 Jun; 84 Suppl EHA-4():70-1. PubMed ID: 10907473
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review.
    Bao L; Lu X; Lai Y; Zhang X; Zhu H; Liu Y; Qin Y; Huang XJ
    Leuk Res; 2009 Jul; 33(7):e64-8. PubMed ID: 19297021
    [No Abstract]   [Full Text] [Related]  

  • 18. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA sequence analysis of a novel variate type of PML/RAR alpha fusion gene transcript].
    Wang GP; Chen FP; Jian ZF
    Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):581-2. PubMed ID: 12536551
    [No Abstract]   [Full Text] [Related]  

  • 20. PML/RAR alpha APL with undifferentiated morphology and stem cell immunophenotype.
    Foley R; Soamboonsrup P; Kouroukis T; Leber B; Carter RF; Sunisloe L; Chorneyko K; Neame PB
    Leukemia; 1998 Sep; 12(9):1492-3. PubMed ID: 9737702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.